Skip to main content

Hodgkin’s Disease

  • Chapter
Cancer in Children

Part of the book series: UICC International Union Against Cancer ((1360))

Abstract

While the aetiology of Hodgkin’s disease remains unknown, the biology of the disease confirms neoplastic behaviour. Cytogenetic studies suggest that the Reed-Sternberg cells, for which this disease was originally named, represent the malignant cells in Hodgkin’s disease. Most authorities believe that this cell is lymphocytic in origin, coming from activated B- or T-lymphocytes. It appears that the Hodgkin’s cell is derived from an immature lymphoid stage of differentiation prior to or during B- or T-cell receptor gene rearrangement [1]. There are many possible sources of transformation in Hodgkin’s cells, including cytogenetic abnormalities, evidence for proto-oncogene involvement and Epstein-Barr virus infection and/or activation. The heterogeneity of the clinical and histological appearance of Hodgkin’s disease and the multitude of different and controversial cellular markers might be explained by the theory that Hodgkin’s disease is a group of aetio-pathophysiologically associated but not identical disease entities.

This research was supported in part by grant CA-34233 from the National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Diehl V, von Kalle C, Fonatsch C, Tesch H, Juecker M, Schaadt M (1990) The cell of origin in Hodgkin’s disease. Sem Oncol 17: 660–672

    CAS  Google Scholar 

  2. Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304: 135–140

    Article  PubMed  CAS  Google Scholar 

  3. Grufferman SL, Delzell E (1984) Epidemiology of Hodgkin’s disease. Epidemiol Rev 6: 76–106

    PubMed  CAS  Google Scholar 

  4. Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66: 2196–2204

    Article  PubMed  CAS  Google Scholar 

  5. Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin P (1966) Report of the Nomenclature Committee. Cancer Res 26: 1311

    Google Scholar 

  6. Parker BR, Castellino RA, Kaplan HS (1976) Pediatric Hodgkin’s disease. I. Radiographic evaluation. Cancer 37: 2430–2435

    Article  PubMed  CAS  Google Scholar 

  7. Donaldson SS, Kaplan HS (1982) A survey of pediatric Hodgkin’s disease at Stanford University: results of therapy and quality of survival. In: Rosenberg SA, Kaplan HS (eds) Malignant lymphomas: etiology, immunology, pathology, and treatment. Academic, New York, pp 571–590

    Google Scholar 

  8. Pao WJ, Kun LE (1989) Hodgkin’s disease in children. Hematol Oncol Clin North Am 3: 345–365

    PubMed  CAS  Google Scholar 

  9. Carbone P, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 31: 1860–1861

    PubMed  CAS  Google Scholar 

  10. Tubiana M, Henry-Amar M, Burgers MV, Van Der Werf-Messing B, Hayatt M (1984) Prognostic significance of ESR in clinical stages I and II Hodgkin’s disease. J Clin Oncol 2: 194–200

    PubMed  CAS  Google Scholar 

  11. Hrgovic M, Tessmer CF, Thomas FB, Fuller LM, Gamble JF, Shullenberger CC (1973) Significance of serum copper in adult patients with Hodgkin’s disease. Cancer 31: 1337–1345

    Article  Google Scholar 

  12. Pui CH, Ip SH, Thompson E, Dodge RK, Brown M, Wilimas J, Carrabis S, Kung P, Berard CW, Crist WM (1989) Increased serum CD8 antigen level in childhood Hodgkin’s disease relates to advanced stage and poor treatment outcome. Blood 73: 209–213

    PubMed  CAS  Google Scholar 

  13. Rostock RA, Siegelman SS, Lenhard RE, Wharam MD, Order SE (1983) Thoracic CT scanning for mediastinal Hodgkin’s disease results and therapeutic implications. Int J Radiat Oncol Biol Phys 9: 1451–1457

    PubMed  CAS  Google Scholar 

  14. Dunnick NR, Parker BR, Castellino RA (1977) Pediatric lymphography: performance, interpretation and accuracy in 193 consecutive children. AJR 129: 639–645

    PubMed  CAS  Google Scholar 

  15. Baker LL, Parker BR, Donaldson SS, Castellino RA (1990) Staging of Hodgkin’s disease in children: comparison of CT and lymphography with laparotomy. AJR 154: 1251–1255

    PubMed  CAS  Google Scholar 

  16. Silverman S, DeNardo GL, Glatstein E, Lipton MJ (1972) Evaluation of the liver and spleen in Hodgkin’s disease. II. The value of splenic scintigraphy. Am J Med 52: 362–366

    Article  PubMed  CAS  Google Scholar 

  17. Horn NL, Ray GR, Kriss JP (1976) Gallium-67 citrate scanning in Hodgkin’s disease and non-Hodgkin’s lymphoma. Cancer 37: 250–257

    Article  PubMed  CAS  Google Scholar 

  18. Green DM, Ghoorah J, Douglass HO, Allen JE, Berjian RJ, Jewett TC, Brecher ML, Henderson ES, Freeman AI (1983) Staging laparotomy with splenectomy in children and adolescents with Hodgkin’s disease. Cancer Treat Rev 10: 23–38

    Article  PubMed  CAS  Google Scholar 

  19. Hagemeister FB, Fesus SM, Lamki LM, Haynie TP (1990) Role of the gallium scan in Hodgkin’s disease. Cancer 65: 1090–1096

    Article  PubMed  CAS  Google Scholar 

  20. Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS (1976) Pediatric Hodgkin’s disease. II. Results of therapy. Cancer 37: 2436–2447

    Article  PubMed  CAS  Google Scholar 

  21. Le Floch O, Donaldson SS, Kaplan HS (1976) Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin’s disease. Cancer 38: 2263–2268

    Article  PubMed  Google Scholar 

  22. Sy Ortin TT, Shostak CA, Donaldson SS (1990) Gonadal status and reproductive function following treatment for Hodgkin’s disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 19: 873–880

    Article  Google Scholar 

  23. Russell KJ, Donaldson SS, Cox RS, Kaplan HS (1984) Childhood Hodgkin’s disease: patterns of relapse. J Clin Oncol 2: 80–87

    PubMed  CAS  Google Scholar 

  24. Garden AS, Woo SY, Fuller LM, Sullivan MP, Ramirez I (1991) Results of a changing treatment philosophy for children with stage I Hodgkin’s disease: a 35-year experience. Med Pediatr Oncol 19: 214–220

    Article  PubMed  CAS  Google Scholar 

  25. Donaldson SS, Link MP (1987) Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin’s disease. J Clin Oncol 5: 742–749

    PubMed  CAS  Google Scholar 

  26. Jenkin D, Doyle J, Berry M, Blanchette V, Chan H, Doherty M, Freedman M, Greenberg M, Panzarella T, Saunders F, Sonley M, Weitzman S, Zipursky A (1990) Hodgkin’s disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. Med Pediatr Oncol 18: 265–272

    Article  PubMed  CAS  Google Scholar 

  27. Donaldson SS, Whitaker SJ, Plowman PN, Link MP, Malpas JS (1990) Stage I—II pediatric Hodgkin’s disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol 8: 1128–1137

    PubMed  CAS  Google Scholar 

  28. Loeffler M, Pfreundschuh M, Ruhl U, Hiller E, Gerhartz H, Roloff R, Adler M, Scoppe W, Hagen-Aukamp V, Schmitt G, Teischmann J, Brust V, Fuchs R, Makoski B, Bartels H, Entzlan J, Kuhn G, Hellriegel A, Kirchner H, Emminger H, Dolken G, Oertel W, Wilhemy W, Kruger B, Petsch S, Pfuger H, Hinterberger R, Worst P, Gossman W, Smith K, Hasenclever D, Deihl V (1989) Risk factor adapted treatment of Hodgkin’s lymphoma: strategies and perspectives. In: Diehl V, Pfreundschuh M, Loeffler M (eds) New aspects in the diagnosis and treatment of Hodgkin’s disease. Springer, Berlin Heidelberg New York, pp 142–162

    Google Scholar 

  29. Schellong G, Waubke-Landwehr A-K, Langermann H-J, Riehm H-J, Bruämswig J, Ritter J (1986) Prediction of splenic involvement in children with Hodgkin’s disease: significance of clinical and intraoperative findings — a retrospective statistical analysis of 154 patients in the German therapy study DAL-HD-78. Cancer 57: 2049–2056

    Article  PubMed  CAS  Google Scholar 

  30. Bramswig JH, Hornig-Franz I, Riepenhausen M, Schellong G (1990) The challenge of pediatric Hodgkin’s disease — where is the balance between cure and long-term toxicity? Leuk Lymphoma 3: 183–193

    Article  Google Scholar 

  31. Andrieu JM, Asselain B, Bayle C, Teillet F, Clot P, Dana M, Katz M, Briere J, Jacquillat C, Bernard J (1981) La séquence polychimiothérapie MOPP-Irradiation ganglionnaire sélective dans le traitement de la maladie de Hodgkin, stades cliniques IA-IIIB. Bull Cancer (Paris) 68: 190–199

    CAS  Google Scholar 

  32. Oberlin O, Boilletot A, Leverger G, Sarrazin D, Lemerle J (1985) Clinical staging, primary chemotherapy and involved field radiotherapy in childhood Hodgkin’s disease. Eur Paediatr Hematol Oncol 2: 65–70

    Article  Google Scholar 

  33. Dionet C, Oberlin O, Habrand J, Vilcoq J, Madelain M, Dutou L, Bey P, Lefur R, Thierry P, LeFloch O, Sarrazin D (1988) Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin’s disease: results of a joint cooperative study by the French Society of Pediatric Oncology and Hopital Saint-Louis, Paris, Int J Radiat Oncol Biol Phys 15: 341–346

    Article  PubMed  CAS  Google Scholar 

  34. Donaldson SS, Link MP, McDougall IR, Parker BR, Shochat S (1989) Clinical investigations of children with Hodgkin’s disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. In: Kamps WA, Humphrey GB, Poppema S (eds) Hodgkin’s disease in children. Controversies and current practice. Kluwer, Boston, pp 307–315

    Google Scholar 

  35. Donaldson SS, Link MP (1991) Hodgkin’s Disease: treatment of the young child. In: Horowitz ME, Pizzo PA (eds) Pediatric clinics of North America. Saunders Philadelphia; 38, pp 457–473

    Google Scholar 

  36. Ekert H, Waters KD, Smith PF, Toogood I, Mauger D (1988) Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin’s disease. J Clin Oncol 6: 1845–1850

    PubMed  CAS  Google Scholar 

  37. Martin J, Radford M (1989) Current practice in Hodgkin’s disease. The United Kingdom Children’s Cancer Study Group. In: Kamps WA, Humphrey GB, Poppema S (eds) Hodgkin’s disease in children: controversies and current practice. Kluwer, Boston, pp 263–275

    Google Scholar 

  38. Behrendt H, van Bunningen B, van Leeuwen EF (1987) Treatment of HD in children without radiotherapy. Cancer 59: 1870–1873

    Article  PubMed  CAS  Google Scholar 

  39. Gehan EA, Sullivan MP, Fuller LM, Johnston BA, Kennedy P, Fryer C, Gilchrist GS, Hays DM, Hanson W, Heller R, Jenkin RDT, Kung F, Sheehan W, Tefft M, Ternberg J, Wharam M (1990) The Intergroup Hodgkin’s Disease in Children. A study of stages I and II. Cancer 65: 1429–1437

    Article  PubMed  CAS  Google Scholar 

  40. Vecchi V, Comelli A, Meloni G, Carli M, Rosati D, DiTullio MT, Madon E, Massalo F, Arico M, Colella R, Macchia PL, Correra A, Bontempi N, DePascale A, Mingozzi P, Burneill R, Pession A (1988) Updated results of protocol MH ‘83 of the Italian Association of Pediatric Hematology and Oncology (AIEOP) for Childhood Hodgkin’s Disease. Proc Int Soc Pediatr Oncol: 155 (abstr)

    Google Scholar 

  41. Leverger G, Oberlin O, Quintana E, Sommelet-Olive D, Phillippe N, Robert A, Bollietot A, Vannier JP, Lejars O, Demeocq F, Perel Y, Pautard B, Lemerle L (1990) ABVD vs MOPP/ ABVD before low-dose radiotherapy in CSIAIIA childhood Hodgkin’s disease (HD). A prospective randomized trial from the French Society of Pediatric Oncology. Proc Am Soc Clin Oncol 9: 273 (abstr)

    Google Scholar 

  42. Vose JM, Bierman PJ, Armitage JO (1990) Hodgkin’s disease: the role of bone marrow transplantation. Sem Oncol 17: 749–757

    CAS  Google Scholar 

  43. Donaldson SS, Kleeberg P, Cox R (1988) Growth abnormalities associated with radiation in children with Hodgkin’s disease. Proc Am Soc Clin Oncol 7: 224

    Google Scholar 

  44. Donaldson SS (1990) Pediatric Hodgkin’s disease: the uniqueness of the pediatric patient. In: Lacher MJ, Redman JR (eds) Hodgkin’s disease: the consequences of survival. Lea and Febiger, Philadelphia, pp 363–382

    Google Scholar 

  45. Donaldson SS, Kaplan HS (1982) Complications of treatment of Hodgkin’s disease in children. Cancer Treat Rep 66: 977–989

    PubMed  CAS  Google Scholar 

  46. Pedrick TJ, Hoppe RT (1986) Recovery of spermatogenesis following pelvic irradiation for Hodgkin’s disease. Int J Radiat Oncol Biol Phys 12: 117–121

    PubMed  CAS  Google Scholar 

  47. da Cuhna MF, Meistrich M, Fuller L, Cundiff JH, Hagemeister FB, Velasquez WS, McLaughlin P, Riggs SA, Cabanillas FF, Salvador PG (1984) Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of MOPP chemotherapy. J Clin Oncol 2: 571–577

    Google Scholar 

  48. Aubier F, Flamant F, Brauner R, Caillaud JM, Chaussain JM, Lemerle J (1989) Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 7: 304–309

    PubMed  CAS  Google Scholar 

  49. Santoro A, Bonadonna G, Valagussa P, Zucali R, Viviani S, Villani F, Pagnoni AM, Bonfante V, Musumeci R, Crippa F, Tess JDT, Banfi A (1987) Long term results of combined chemotherapy-radiotherapy approach in Hodgkin’s disease. Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5: 27–37

    PubMed  CAS  Google Scholar 

  50. Green DM, Brecher ML, Yakar D, Blumenson LE, Lindsay AN, Voorhess ML, MacGillivray M, Freeman AI (1980) Thyroid function in pediatric patients after neck irradiation for Hodgkin’s disease. Med Pediatr Oncol 8: 127–136

    Article  PubMed  CAS  Google Scholar 

  51. Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS (1984) Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 53: 878–883

    Article  PubMed  CAS  Google Scholar 

  52. Kadota RP, Burgert EO, Driscoll DJ, Evans RG, Gilchrist GS (1988) Cardiopulmonary function in long-term survivors of childhood Hodgkin’s lymphoma: a pilot study. Mayo Clin Proc 63: 362–367

    PubMed  CAS  Google Scholar 

  53. Fryer CJ, Hutchinson RJ, Krailo M, Collins RD, Constine LS, Hays DM, Heller RM, Davis PC, Nachman J, O’Brien RT, O’Neill JP, Pringle KC, Trigg ME, Hammond GD (1990) Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin’s disease in children: a report from the Childrens Cancer Study Group. J Clin Oncol 8: 1971–1980

    PubMed  CAS  Google Scholar 

  54. Mefferd J, Donaldson SS, Link MP (1989) Pediatric Hodgkin’s disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 16: 679–685

    Article  PubMed  CAS  Google Scholar 

  55. McReynolds RA, Gold GL, Robert WC (1976) Coronary heart disease after mediastinal irradiation for Hodgkin’s disease. Am J Med 60: 39–45

    Article  PubMed  CAS  Google Scholar 

  56. Chilcote RR, Baehner RL, Hammond D, Childrens Cancer Study Group (1976) Septicemia and meningitis in children splenectomized for Hodgkin’s disease. N Engl J Med 295: 798–800

    Article  PubMed  CAS  Google Scholar 

  57. Donaldson SS, Glatstein E, Vosti KL (1978) Bacterial infections in pediatric Hodgkin’s disease: relationship to radiotherapy, chemotherapy, and splenectomy. Cancer 41: 1949–1958

    Article  PubMed  CAS  Google Scholar 

  58. Rosenstock JG, D’Angio GJ, Kiesewetter WB (1974) The incidence of complications following staging laparotomy for Hodgkin’s disease in children. Radiology 120: 531–535

    CAS  Google Scholar 

  59. Donaldson SS, Vosti KL, Berberich FR, Cox RS, Kaplan HS, Schiffman G (1981) Response to pneumococcal vaccine among children with Hodgkin’s disease. Rev Infect Dis 3: S133 - S143

    Article  PubMed  Google Scholar 

  60. Meadows AT, Obringer AC, Marrero O, Oberlin O, Robison L, Fossati-Bellani F, Green D, Voute PA, Morris-Jones P, Greenberg M, Baum E, Ruymann F (1989) Second malignant neoplasms following childhood Hodgkin’s disease: treatment and splenectomy as risk factors. Med Pediatr Oncol 17: 477–484

    Article  PubMed  CAS  Google Scholar 

  61. van Leeuwen FE, Somers R, Hart AAM (1987) Splenectomy in Hodgkin’s disease and second leukaemias. Lancet 2: 210–211

    Article  PubMed  Google Scholar 

  62. Kaldor JM, Day NE, Clark EA, Van Leeuwen FE, Henry-Amar M, Fiorento MV, Bell J, Pedersen D, Band P, Assouline D, Koch M, Choi W, Prior P, Blair V, Longmark F, Kirn VP, Neal F, Peters D, Pfeiffer R, Karjalaiena S, Cuzick J, Sutcliffe S, Somers R, Pellae-Cosset B, Pappagallo GL, Fraser P, Storm H, Stovall M (1990) Leukemia following Hodgkin’s disease. N Engl J Med 322: 7–13

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Donaldson, S.S., Oberlin, O. (1992). Hodgkin’s Disease. In: Voûte, P.A., Barrett, A., Lemerle, J. (eds) Cancer in Children. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84722-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84722-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84724-0

  • Online ISBN: 978-3-642-84722-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics